BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  InnoCare Announces Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Sjögren’s Syndrome in China

  May 8, 2026

   · 

  3 min read
• Press Releases

  Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering

  May 8, 2026

   · 

  4 min read
• Press Releases

  Chance Pharma Announces NMPA Acceptance of New Drug Application for Investigational Respiratory Drug CXG87

  May 8, 2026

   · 

  5 min read
• Press Releases

  Mobia Medical Announces Pricing of Initial Public Offering

  May 8, 2026

   · 

  2 min read
• Press Releases

  Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease

  May 8, 2026

   · 

  18 min read
• Press Releases

  Rznomics Announces U.S. FDA Regenerative Medicine Advanced Therapy Designation Granted to ‘RZ-001' for Hepatocellular Carcinoma

  May 8, 2026

   · 

  3 min read
• Press Releases

  Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors

  May 8, 2026

   · 

  3 min read
• Press Releases

  Genflow Biosciences PLC Announces Exercise of Warrants and Issue of Equity

  May 8, 2026

   · 

  3 min read
• Press Releases

  Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology

  May 8, 2026

   · 

  2 min read
• Press Releases

  Pharvaris Announces Pricing of $115 Million Underwritten Offering of Ordinary Shares

  May 8, 2026

   · 

  6 min read